Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer.
about
Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasisFOXM1 confers acquired cisplatin resistance in breast cancer cellsThe Role of Forkhead Box Protein M1 in Breast Cancer Progression and Resistance to TherapyPrognostic Value of FOXM1 in Patients with Malignant Solid Tumor: A Meta-Analysis and System ReviewRegulation of epithelial-mesenchymal transition through epigenetic and post-translational modificationsUnsupervised feature construction and knowledge extraction from genome-wide assays of breast cancer with denoising autoencodersIntegrating Multi-omics Data to Dissect Mechanisms of DNA repair Dysregulation in Breast CancerIntegration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.Forkhead box M1 transcription factor: a novel target for cancer therapy.Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis.Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression.FoxM1 mediates resistance to herceptin and paclitaxel.FoxM1 is a novel target of a natural agent in pancreatic cancer.Down-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells.MicroRNA-194 inhibits the epithelial-mesenchymal transition in gastric cancer cells by targeting FoxM1.Overexpression of FOXM1 is associated with metastases of nasopharyngeal carcinomaIdentification of early molecular markers for breast cancer.Proteasome inhibitors in cancer therapyInsulin-like growth factor-1 receptor signaling increases the invasive potential of human epidermal growth factor receptor 2-overexpressing breast cancer cells via Src-focal adhesion kinase and forkhead box protein M1.Resistance to HER2-targeted therapies: a potential role for FOXM1.Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells.The 26S proteasome complex: an attractive target for cancer therapyFoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.Nucleophosmin interacts with FOXM1 and modulates the level and localization of FOXM1 in human cancer cells.Investigation of FOXM1 as a Potential New Target for Melanoma.FOXM1 is overexpressed in B-acute lymphoblastic leukemia (B-ALL) and its inhibition sensitizes B-ALL cells to chemotherapeutic drugsFoxM1 regulates mammary luminal cell fateThe critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis.MEK inhibition increases lapatinib sensitivity via modulation of FOXM1Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells.p28, a first in class peptide inhibitor of cop1 binding to p53.Identification of potential therapeutic targets in malignant mesothelioma using cell-cycle gene expression analysisHedgehog signalling in breast cancer.Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells.3,3'-Diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through downregulation of FoxM1.Prognostic discrimination using a 70-gene signature among patients with estrogen receptor-positive breast cancer and an intermediate 21-gene recurrence score.A conserved phosphorylation site within the forkhead domain of FoxM1B is required for its activation by cyclin-CDK1.ErbB2, FoxM1 and 14-3-3ζ prime breast cancer cells for invasion in response to ionizing radiation.A new target for proteasome inhibitors: FoxM1
P2860
Q24613046-3F6AA3CB-7DEF-46B6-ABB7-253F24A86415Q24642596-2E950515-12D0-48B5-8209-FA2ACEFC5C31Q26768290-F8F2D178-63A4-43CD-B63C-B28E58F015B8Q26785676-084D6E0C-894A-4EA3-BB1D-191E054A9D69Q28076697-6C21A51A-476A-4D67-9C97-500C0E463DCFQ30616727-ADC071D2-35AF-488D-BE7E-B62D5C08AB55Q31132980-29ECD159-975E-4C4A-B23E-FBC68BA9872FQ33670486-A73EB238-F247-4395-9CF1-8CBCD17A822EQ33729250-4F49280E-A558-4B33-A687-1888F248B2A1Q33762091-F2DB3601-31A7-4E00-A9D3-07C985DA5BEEQ33864523-61D56881-6324-4A18-B252-42A203FF82C5Q33946664-851907AE-BC0A-42ED-B0D6-57AFCD8227D0Q34286063-BF7DA1AC-4BA9-4151-AAF2-B2B1881A0CB4Q34371119-5529FD97-AA3B-4DD0-A6D0-AEE61CB20AF1Q34416069-AC6658D5-49E1-47FD-B225-7A613AB4E4BDQ34589178-E4A6BC53-F482-4B09-AE7C-34DAE7947C3BQ34608080-0F023AE1-E5C0-4B65-8C66-81E0272720CEQ34939959-FB2C71D5-4519-4213-8333-DBCB3A21D264Q34946846-BE862ED3-8A20-4FC0-AF38-C62EBC961FA3Q34955355-11BD1463-E859-4A33-9AD0-549A70103421Q35163008-0113BFC1-F490-4A16-8379-C27F226B50B4Q35624079-2A4EE493-1DE3-43E9-B9D3-A1E255C4FC03Q35793788-DFB22184-8B84-4685-B961-A15A39ED1884Q35800767-8A6E4D24-FA23-4DAF-87BC-8A07D96DD156Q35842155-C7D911D6-8E39-477F-B2D6-CDE455C5AB6CQ35861978-896B5E57-8E8C-440D-A636-F48829F6226CQ36094104-A09B42D9-AD40-4C3A-83E1-EECD4E8990B5Q36106731-762089DA-3B4E-4B96-9E87-70A55F9F9A88Q36510909-56F93280-7DF0-4747-8548-4E36FD55C1CBQ36833298-B23EF451-7F15-4F8C-9EBF-568702E2AC5EQ36872440-2DAF3436-088D-4B96-9B3E-B78EED396B5AQ36959166-A8C6FACF-9FBD-40AF-9B6A-91DA768718FCQ37150740-014EF2CA-686A-4461-B04C-ADBB3C8825EBQ37214195-EC4617F8-C044-407E-B48B-959F14148E87Q37220370-BE901C75-CC06-47EA-837C-0ECC39D3327EQ37243057-E18D15E6-0115-4CEE-BF28-81A59A177E9AQ37420876-03F45857-8E09-45B8-8317-EE561DB25F8DQ37431862-A03F57A6-C369-4FC3-A270-AFE15F336167Q37663938-95E90696-E1E1-4B15-858D-5164850CF962Q37674617-62BDCB93-E7A0-4113-BEE4-183E7D16C9EC
P2860
Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Tight correlation between expr ...... d HER2 in human breast cancer.
@ast
Tight correlation between expr ...... d HER2 in human breast cancer.
@en
Tight correlation between expr ...... d HER2 in human breast cancer.
@nl
type
label
Tight correlation between expr ...... d HER2 in human breast cancer.
@ast
Tight correlation between expr ...... d HER2 in human breast cancer.
@en
Tight correlation between expr ...... d HER2 in human breast cancer.
@nl
prefLabel
Tight correlation between expr ...... d HER2 in human breast cancer.
@ast
Tight correlation between expr ...... d HER2 in human breast cancer.
@en
Tight correlation between expr ...... d HER2 in human breast cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Tight correlation between expr ...... d HER2 in human breast cancer.
@en
P2093
Anette ten Haaf
Arndt Hartmann
Edgar Dahl
Nuran Bektas
Peter Johannes Wild
P2860
P2888
P356
10.1186/1471-2407-8-42
P407
P577
2008-02-06T00:00:00Z
P5875
P6179
1030346880